MyLeukemiaTeam

What is Danziten and how is it used to treat chronic myeloid leukemia (CML)?

Danziten is a newly FDA-approved form of nilotinib (2024) that offers more flexibility for patients. It can be used for
• Newly diagnosed chronic phase Ph-positive CML
• Chronic or accelerated phase Ph-positive CML that is resistant to other Show Full Answer

What is Danziten and how is it used to treat chronic myeloid leukemia (CML)?

Danziten is a newly FDA-approved form of nilotinib (2024) that offers more flexibility for patients. It can be used for:
• Newly diagnosed chronic phase Ph-positive CML
• Chronic or accelerated phase Ph-positive CML that is resistant to other treatments

The main advantage of Danziten over older nilotinib medications (like Tasigna) is that it can be taken with food, eliminating the need for fasting around medication times. Common side effects of Danziten include:
• Nausea
• Headache
• Fatigue
• Vomiting and diarrhea
• Fevers
• Night sweats

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

5 Tips To Relieve Side Effects From CML Treatment

Tyrosine Kinase Inhibitor Therapy vs. Chemotherapy: What Works Better for CML?